Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


11.02.2019

2 AJNR Am J Neuroradiol
3 BMC Cancer
2 Cancer
2 Cancer Res
2 Childs Nerv Syst
2 Eur J Cancer
2 Int J Cancer
1 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
9 J Neurooncol
1 J Neurosurg
1 Mayo Clin Proc
1 Nat Rev Cancer
4 Neuro Oncol
3 Neuroradiology
1 Oncogene
1 PLoS Genet
4 PLoS One
1 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. PRASANNA P, Rogers L, Lam TC, Cohen M, et al
    Disorder in Pixel-Level Edge Directions on T1WI Is Associated with the Degree of Radiation Necrosis in Primary and Metastatic Brain Tumors: Preliminary Findings.
    AJNR Am J Neuroradiol. 2019 Feb 7. pii: ajnr.A5958. doi: 10.3174/ajnr.A5958.
    PubMed     Text format     Abstract available

  2. BATCHALA PP, Muttikkal TJE, Donahue JH, Patrie JT, et al
    Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in IDH-Mutant Lower Grade Gliomas.
    AJNR Am J Neuroradiol. 2019 Jan 31. pii: ajnr.A5957. doi: 10.3174/ajnr.A5957.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. VALKONEN M, Haapasalo H, Rilla K, Tyynela-Korhonen K, et al
    Elevated expression of hyaluronan synthase 2 associates with decreased survival in diffusely infiltrating astrocytomas.
    BMC Cancer. 2018;18:664.
    PubMed     Text format     Abstract available

  4. HEYNCKES S, Daka K, Franco P, Gaebelein A, et al
    Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme.
    BMC Cancer. 2019;19:117.
    PubMed     Text format     Abstract available

  5. KIM T, Choi HY, Lee HS, Jung SH, et al
    Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL).
    BMC Cancer. 2018;18:729.
    PubMed     Text format     Abstract available


    Cancer

  6. MARAKA S, Groves MD, Penas-Prado M
    Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma.
    Cancer. 2019 Feb 1. doi: 10.1002/cncr.31960.
    PubMed     Text format    

  7. NEVIN RL
    Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma.
    Cancer. 2019 Feb 1. doi: 10.1002/cncr.31961.
    PubMed     Text format    


    Cancer Res

  8. MASTRELLA G, Hou M, Li M, Stoecklein VM, et al
    Targeting APLN/APLNR improves anti-angiogenic efficiency and blunts pro-invasive side effects of VEGFA/VEGFR2-blockade in glioblastoma.
    Cancer Res. 2019 Feb 4. pii: 0008-5472.CAN-18-0881.
    PubMed     Text format     Abstract available

  9. ATKINS I, Kinnersley B, Ostrom QT, Labreche K, et al
    Transcriptome-wide association study identifies new candidate susceptibility genes for glioma.
    Cancer Res. 2019 Feb 1. pii: 0008-5472.CAN-18-2888.
    PubMed     Text format     Abstract available


    Childs Nerv Syst

  10. GELDER CL, Hawkins C, Zapotocky M, Dirks P, et al
    Diffuse intrinsic pontine glioma ventricular peritoneal shunt metastasis: a case report and literature review.
    Childs Nerv Syst. 2019 Jan 31. pii: 10.1007/s00381-019-04069.
    PubMed     Text format     Abstract available

  11. PEREZ-SOMARRIBA M, Andion M, Lopez-Pino MA, Lavarino C, et al
    Old drugs still work! Oral etoposide in a relapsed medulloblastoma.
    Childs Nerv Syst. 2019 Feb 1. pii: 10.1007/s00381-019-04072.
    PubMed     Text format     Abstract available


    Eur J Cancer

  12. URSU R, Thomas L, Psimaras D, Chinot O, et al
    Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma-a randomised multicentre trial (ASTER trial). An ANOCEF study.
    Eur J Cancer. 2019;109:129-136.
    PubMed     Text format     Abstract available

  13. SHINJO D, Matsumoto K, Terashima K, Takimoto T, et al
    Volume effect in paediatric brain tumour resection surgery: analysis of data from the Japanese national inpatient database.
    Eur J Cancer. 2019;109:111-119.
    PubMed     Text format     Abstract available


    Int J Cancer

  14. CHEN H, Chen G, Li G, Zhang S, et al
    Two novel genetic variants in the STK38L and RAB27A genes are associated with glioma susceptibility.
    Int J Cancer. 2019 Feb 4. doi: 10.1002/ijc.32179.
    PubMed     Text format     Abstract available

  15. RAASCHOU-NIELSEN O, Hvidtfeldt U, Roswall N, Hertel O, et al
    Ambient benzene at the residence and risk for subtypes of childhood leukaemia, lymphoma and CNS tumour.
    Int J Cancer. 2018 Apr 6. doi: 10.1002/ijc.31421.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  16. DIRVEN L, Reijneveld JC, Taphoorn MJB, Coens C, et al
    Impact of radiation target volume on health-related quality of life in patients with low grade glioma in the two-year period post treatment - XXX.
    Int J Radiat Oncol Biol Phys. 2019 Feb 1. pii: S0360-3016(19)30038.
    PubMed     Text format     Abstract available


    J Clin Oncol

  17. WEN PY, Touat M, Alexander BM, Mellinghoff IK, et al
    Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial.
    J Clin Oncol. 2019 Feb 4:JCO1801207. doi: 10.1200/JCO.18.01207.
    PubMed     Text format     Abstract available

  18. SALLOUM R, Chen Y, Yasui Y, Packer R, et al
    Late Morbidity and Mortality Among Medulloblastoma Survivors Diagnosed Across Three Decades: A Report From the Childhood Cancer Survivor Study.
    J Clin Oncol. 2019 Feb 7:JCO1800969. doi: 10.1200/JCO.18.00969.
    PubMed     Text format     Abstract available


    J Neurooncol

  19. MAHATO D, Vivas-Buitrago T, Gassie K, Jentoft M, et al
    Intracranial melanotic schwannomas: a rare variant with unusual adherent features.
    J Neurooncol. 2018;136:299-306.
    PubMed     Text format     Abstract available

  20. CHOWDHARY M, Okwan-Duodu D, Switchenko JM, Press RH, et al
    Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery.
    J Neurooncol. 2018;136:289-298.
    PubMed     Text format     Abstract available

  21. NANDA T, Yaeh A, Wu CC, Jani A, et al
    Local control and overall survival for adjuvant stereotactic radiosurgery in patients with residual or recurrent disease.
    J Neurooncol. 2018;136:281-287.
    PubMed     Text format     Abstract available

  22. JIANG C, Wang J
    Post-traumatic stress disorders in patients with low-grade glioma and its association with survival.
    J Neurooncol. 2019 Jan 31. pii: 10.1007/s11060-019-03112.
    PubMed     Text format     Abstract available

  23. WU M, Miska J, Xiao T, Zhang P, et al
    Race influences survival in glioblastoma patients with KPS >/= 80 and associates with genetic markers of retinoic acid metabolism.
    J Neurooncol. 2019 Jan 31. pii: 10.1007/s11060-019-03110.
    PubMed     Text format     Abstract available

  24. SILVANI A, De Simone I, Fregoni V, Biagioli E, et al
    Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma.
    J Neurooncol. 2019 Feb 6. pii: 10.1007/s11060-019-03116.
    PubMed     Text format     Abstract available

  25. KALLAY L, Keskin H, Ross A, Rupji M, et al
    Modulating native GABAA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death.
    J Neurooncol. 2019 Feb 6. pii: 10.1007/s11060-019-03115.
    PubMed     Text format     Abstract available

  26. NA K, Kim HS, Shim HS, Chang JH, et al
    Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases.
    J Neurooncol. 2019 Feb 1. pii: 10.1007/s11060-019-03114.
    PubMed     Text format     Abstract available

  27. BRIGELL RH, Cagney DN, Martin AM, Besse LA, et al
    Local control after brain-directed radiation in patients with cystic versus solid brain metastases.
    J Neurooncol. 2019 Feb 4. pii: 10.1007/s11060-019-03106.
    PubMed     Text format     Abstract available


    J Neurosurg

  28. BO HK, Solheim O, Kvistad KA, Berntsen EM, et al
    Intraoperative 3D ultrasound-guided resection of diffuse low-grade gliomas: radiological and clinical results.
    J Neurosurg. 2019 Feb 1:1-12. doi: 10.3171/2018.10.JNS181290.
    PubMed     Text format     Abstract available


    Mayo Clin Proc

  29. CERHAN JH, Butts AM, Syrjanen JA, Aakre JA, et al
    Factors Associated With Meningioma Detected in a Population-Based Sample.
    Mayo Clin Proc. 2019;94:254-261.
    PubMed     Text format     Abstract available


    Nat Rev Cancer

  30. BARATTA MG
    Glioblastoma is 'hot' for personalized vaccines.
    Nat Rev Cancer. 2019 Jan 31. pii: 10.1038/s41568-019-0118.
    PubMed     Text format    


    Neuro Oncol

  31. PIGEON H, Peres EA, Truillet C, Jego B, et al
    TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma.
    Neuro Oncol. 2019 Feb 5. pii: 5307172. doi: 10.1093.
    PubMed     Text format     Abstract available

  32. HSIEH TH, Liu YR, Chang TY, Liang ML, et al
    Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors.
    Neuro Oncol. 2018;20:519-530.
    PubMed     Text format     Abstract available

  33. KIM JM, Miller JA, Kotecha R, Chao ST, et al
    Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis.
    Neuro Oncol. 2019 Feb 6. pii: 5288601. doi: 10.1093.
    PubMed     Text format     Abstract available

  34. BRANZOLI F, Pontoizeau C, Tchara L, Di Stefano AL, et al
    Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy.
    Neuro Oncol. 2019 Feb 6. pii: 5308111. doi: 10.1093.
    PubMed     Text format     Abstract available


    Neuroradiology

  35. DI IEVA A, Choi C, Magnussen JS
    Spectrobiopsy in neurodiagnostics: the new era.
    Neuroradiology. 2018;60:129-131.
    PubMed     Text format    

  36. KIVINIEMI A, Gardberg M, Ek P, Frantzen J, et al
    Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents.
    Neuroradiology. 2019 Feb 2. pii: 10.1007/s00234-019-02172.
    PubMed     Text format     Abstract available

  37. LATYSHEVA A, Emblem KE, Brandal P, Vik-Mo EO, et al
    Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach.
    Neuroradiology. 2019 Feb 2. pii: 10.1007/s00234-019-02173.
    PubMed     Text format     Abstract available


    Oncogene

  38. CHU Y, Elrod N, Wang C, Li L, et al
    Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
    Oncogene. 2019 Jan 31. pii: 10.1038/s41388-019-0714.
    PubMed     Text format     Abstract available


    PLoS Genet

  39. SUN G, Ding X, Bi N, Wang Z, et al
    Molecular predictors of brain metastasis-related microRNAs in lung adenocarcinoma.
    PLoS Genet. 2019;15:e1007888.
    PubMed     Text format     Abstract available


    PLoS One

  40. VOLNITSKIY A, Shtam T, Burdakov V, Kovalev R, et al
    Abnormal activity of transcription factors gli in high-grade gliomas.
    PLoS One. 2019;14:e0211980.
    PubMed     Text format     Abstract available

  41. BENAVIDES-SERRATO A, Lee J, Holmes B, Landon KA, et al
    Correction: Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.
    PLoS One. 2019;14:e0212160.
    PubMed     Text format     Abstract available

  42. LANGE F, Wesslau K, Porath K, Hornschemeyer J, et al
    AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro.
    PLoS One. 2019;14:e0211644.
    PubMed     Text format     Abstract available

  43. CAREY MR, Callaghan BC, Kerber KA, Skolarus LE, et al
    Impact of early headache neuroimaging on time to malignant brain tumor diagnosis: A retrospective cohort study.
    PLoS One. 2019;14:e0211599.
    PubMed     Text format     Abstract available


    Rev Neurol

  44. CASTRILLO A, Cerdan D, Eguizabal J, Mendoza-Rodriguez A, et al
    [New case of intradural extramedullary capillary haemangioma].
    Rev Neurol. 2018;67:155-156.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: